Open AccessEmergence of blaNDM-5-producing Escherichia coli ST410 in Companion Dogs Treated with Meropenem
Author(s) -
Jy Oh
Publication year - 2020
Publication title -
pakistan veterinary journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.281
H-Index - 29
eISSN - 2074-7764
pISSN - 0253-8318
DOI - 10.29261/pakvetj/2020.073
Subject(s) - meropenem , escherichia coli , biology , microbiology and biotechnology , plasmid , enterobacteriaceae , carbapenem , pulsed field gel electrophoresis , carbapenem resistant enterobacteriaceae , antibiotics , gene , antibiotic resistance , genotype , genetics
Carbapenem-resistant Escherichia coli (CRE) with a multidrug resistant phenotype was isolated from four clinically ill dogs treated with meropenem in different local animal hospitals between 2017 and 2019. IncX3-type plasmids of ca. 46 kb in size carrying blaNDM-5 were present in all CRE strains and their transconjugants. High genetic similarity (>90%) by PFGE analysis was observed among the CRE strains, which were identified as ST410.To the best of our knowledge, blaNDM-5-producing E. coli ST410 clones are emerging sporadically in companion dogs treated with meropenem. The spread of Enterobacteriaceae harboring the NDM-5 gene in companion animals can pose a threat to public health; therefore, extensive monitoring in veterinary hospitals using carbapenem and careful antibiotic use are crucial for managing and monitoring these resistant strains